PRESS RELEASES

Date	Title and Summary	Additional Formats
Toggle SummaryOct 9, 2013	Integra LifeSciences Announces Introduction of Integra(R) Hollywood(TM) NanoMetalene(TM) Interbody Device Company's First Spinal Implant Using Proprietary NanoMetalene Coating Technology	View HTML Integra LifeSciences Announces Introduction of Integra(R) Hollywood(TM) NanoMetalene(TM) Interbody Device 12 KB
Toggle SummaryOct 2, 2013	Integra LifeSciences Announces Podium Presentation of NeuraGen(R) Nerve Guide Multi-Center Clinical Trial at ASSH PLAINSBORO, N.J., Oct. 2, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the Podium Presentation of A Collagen Conduit vs. Microsurgical Neurorrhaphy. Two-Year Follow up of a Prospective Blinded Clinical and Electrophysiological Multicenter RCT , at	View HTML Integra LifeSciences Announces Podium Presentation of NeuraGen(R) Nerve Guide Multi-Center Clinical Trial at ASSH 11.3 KB
Toggle SummarySep 26, 2013	Integra LifeSciences Announces Resolution of Warning Letter Related to Its Plainsboro, NJ, Manufacturing Facility PLAINSBORO, N.J., Sept. 26, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that the United States Food and Drug Administration ("FDA") has informed the Company that it had addressed the violations in the warning letter relating to its Plainsboro,	View HTML Integra LifeSciences Announces Resolution of Warning Letter Related to Its Plainsboro, NJ, Manufacturing Facility 9.1 KB
Toggle SummarySep 23, 2013	Integra LifeSciences Announces First Implantation of Titan(TM) Reverse Shoulder System PLAINSBORO, N.J., Sept. 23, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the first implantation of its Integra® Titan™ Reverse Shoulder System, in the United States. The system, which is used in the treatment of shoulder replacement surgery, was	View HTML Integra LifeSciences Announces First Implantation of Titan(TM) Reverse Shoulder System 10.9 KB
Toggle SummaryAug 29, 2013	Integra LifeSciences to Participate in Investor Conferences in September PLAINSBORO, N.J., Aug. 29, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present at the following conferences in the next few weeks: - At 11:10 AM ET on Wednesday, September 11, 2013, Mr.	View HTML Integra LifeSciences to Participate in Investor Conferences in September 10.8 KB
Toggle SummaryAug 27, 2013	Integra LifeSciences Holdings Corporation Appoints Donald E. Morel, Jr., Ph.D. as a Director and Announces Retirement of Neal Moszkowski as a Director PLAINSBORO, N.J., Aug. 27, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that, effective today, Mr. Neal Moszkowski has retired from the Board of Directors. The Board has appointed Donald Morel as a Director of the Company.	View HTML Integra LifeSciences Holdings Corporation Appoints Donald E. Morel, Jr., Ph.D. as a Director and Announces Retirement of Neal Moszkowski as a Director 10.6 KB
Toggle SummaryAug 1, 2013	Integra LifeSciences Reports Second Quarter 2013 Financial Results Revenue in Line With Guidance	View HTML Integra LifeSciences Reports Second Quarter 2013 Financial Results 47.5 KB
Toggle SummaryJul 31, 2013	Integra LifeSciences Receives FDA Clearance for Titan(TM) Reverse Shoulder System Offers Greater Flexibility for Shoulder Replacement Surgery	View HTML Integra LifeSciences Receives FDA Clearance for Titan(TM) Reverse Shoulder System 12.1 KB
Toggle SummaryJul 18, 2013	Integra LifeSciences Offers Surgeons More Foot Fixation Options With Next-Generation Total Foot System Features System at 2013 American Orthopaedic Foot and Ankle Society (AOFAS) Annual Meeting	View HTML
Toggle SummaryJul 3, 2013	Integra LifeSciences to Host Its Second Quarter 2013 Earnings Results Conference Call on August 1, 2013 PLAINSBORO, N.J., July 3, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) will release its second quarter 2013 financial results on Thursday, August 1, 2013. The company has scheduled a conference call for 8:30 AM ET the same day to discuss the results.	View HTML Integra LifeSciences to Host Its Second Quarter 2013 Earnings Results Conference Call on August 1, 2013 9.9 KB
Toggle SummaryJun 26, 2013	Integra LifeSciences Announces CE Mark and European Launch of Integra(R) Smart Cervical Solution PLAINSBORO, N.J., June 26, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has received European CE Mark for its Integra ® Smart Cervical Solution, a device approved in the European Union for treating degenerative diseases of the cervical	View HTML Integra LifeSciences Announces CE Mark and European Launch of Integra(R) Smart Cervical Solution 12.7 KB
Toggle SummaryMay 29, 2013	Integra LifeSciences to Participate in Investor Conferences in June PLAINSBORO, N.J., May 29, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present at the following conferences in the next few weeks: At 4:00 PM ET on Tuesday, June 4, 2013, Mr. Peter Arduini, President and Chief Executive Officer of	View HTML Integra LifeSciences to Participate in Investor Conferences in June 10.6 KB
Toggle SummaryMay 7, 2013	Integra LifeSciences to Participate in Investor Conferences in May PLAINSBORO, N.J., May 7, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present at the following conferences in the next few weeks: - At 3:00 PM PT on Tuesday, May 14, 2013, Jack Henneman, Chief Financial Officer of Integra, will	View HTML Integra LifeSciences to Participate in Investor Conferences in May 11.3 KB
Toggle SummaryMay 2, 2013	Integra LifeSciences Reports First Quarter 2013 Financial Results Results In Line With Preliminary Announcement Revises 2013 Guidance PLAINSBORO, N.J., May 2, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported its financial results for the first quarter ending March 31, 2013.	View HTML Integra LifeSciences Reports First Quarter 2013 Financial Results 44.4 KB
Toggle SummaryApr 30, 2013	Integra LifeSciences Introduces Hollywood VI Spinal Fusion System Offers Surgeons a Variable Insertion Option and Multiple Implant Sizes	View HTML Integra LifeSciences Introduces Hollywood(TM) VI Spinal Fusion System 11.4 KB